Translational Regenerative Medicine: Market Prospects 2014-2024

Translational Regenerative Medicine:Translational Regenerative Medicine: Market Prospects 2014-2024 PR Newswire LONDON, November 28, 2013 Our new study shows you the commercial potential of regenerative treatments What does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our study lets you assess regenerative medicine: cell-based therapies that aim to restore function and regenerate diseased tissues. It lets you assess projected sales at world market, market segment, product and regional level to 2024. You will see financial results, interviews, trends, opportunities, and revenue predictions. In our investigation you also see qualitative analyses, news R&D and business developments. Our 240 page report provides 122 tables, charts, and graphs. Read the full transcripts of three exclusive expert opinion interviews from leading industry specialists informing your understanding and allowing you to assess prospects for investments and sales: • Dr. Alan Trounson - President, California Institute for Regenerative Medicine (CIRM) • Professor Francois Berthiaume - Associate Professor of Biomedical Engineering, Rutgers University, New Jersey • Dr.